HYALURONIC ACID WITH POLYETHYLENE GLYCOL 400 WITH PROPYLENE GLYCOL WITH HYDROXYPROPYL GUAR
Information current as at: 1 June 2025
The pharmaceutical company has advised that it is not proceeding in the PBS listing process at this time. The process for listing this medicine has ceased.
Submission Details
- Brand name:
-
- Systane® Hydration
- Pharmaceutical company:
- Alcon Laboratories (Australia) Pty Ltd
- Condition/indication:
(therapeutic use) -
- Severe dry eye syndrome
- PBAC Submission type:
- New PBS listing (–)
- Comment:
- --
- Public Summary Document:
- PBAC Public Summary Documents – May 2023
Progress Details
-
Submission received for: - May 2023 PBAC meeting
-
Opportunity for consumer comment: - Open 23/11/2022 and close 25/01/2023 (see PBS Website)
-
PBAC meeting: - Held on 05/05/2023
-
Lodgement of required documentation: - Not applicable
-
Agreement to listing arrangements: - Not applicable
-
Government processes: - Not applicable
-
Medicine listed on the PBS: - Not applicable
Case ID: a735
Page last updated: 02 May 2024